Pharmaceutical From Standard to Specialist Capsule Formats Hard gelatin, HPMC, inhalation and vaginal formats engineered for every therapeutic need.
Nutraceutical Consumer-Ready Nutraceutical Formats Capsules and branded ingredients built for supplement manufacturers who demand differentiation.
Pharmaceutical CDMO
Accelerating Drug Development
Our Innovaform Accelerator and Tampa facility combine formulation science with scalable manufacturing.
CDMO Partnership
Full-Service Nutraceutical Manufacturing
From concept to market-ready product — your end-to-end nutraceutical development partner.
Applications
Our Story
Partners in Drug Delivery Innovation
A global leader in capsule technologies, committed to advancing pharmaceutical and nutraceutical science.
Filter by:
Market
Content Type
Product Portfolio
Innovation in oral formulation technologies has opened new avenues for the lifecycle management and patent protection of biologics. Technologies such as SNAC, LBFs,…
The success and adoption of oral GLP-1 RAs mark a shift in biologic drug delivery. Technologies such as permeation enhancers, LBFs, and enteric protection have made…
Healthcare systems are facing increasing pressure as record demand, an aging population, the burden of chronic disease, and economic inflation challenge clinics,…
Discover how Lonza Capsugel helps you overcome durg product development challenges, accelerate timelines, and unlock new opportunities for innovation
This expert-led session explores the latest advancements in oral delivery systems for emerging drug modalities, with a particular focus on peptides and other complex…
Poster presentation delivered at the Controlled Release Society (CRS) Annual Meeting, 2025.
At the Innovaform® Accelerator, we’re commited to advancing drug delivery through collaboration and cutting-edge science.
Explore how Lonza’s advanced polymer science and capsule manufacturing capabilities - Capsugel® Enprotect® - have led to a breakthrough in enteric protection.
Unlocking the full potential of many therapies hinges on effective absorption in the lower GI tract. Yet, delivering fragile APIs to the right location is no small…
The lower gastrointestinal tract is critical for enhancing bioavailability and drug absorption, directly influencing therapeutic efficacy.
Enteric capsules have many applications. Their principal purpose is to prevent the release of active pharmaceutical ingredients (APIs) in the stomach and to avoid…
The lower GI tract plays an important role in how well drugs are absorbed and utilized by the body. But delivering sensitive APIs to this region—especially those…
The lower gastro-intestinal tract plays an important role in optimizing bio-availability and drug absorption – and therefore the effectiveness of many therapies. But…
These findings confirm that Capsugel® Enprotect® capsules offer a robust, scalable, & patient-friendly alternative to traditional double-encapsulation methods
This downloadable summary features findings from a peer-reviewed study evaluating the in vivo performance of Capsugel® Enprotect® capsules
Delve contrasts between traditional coating methods with newer bi-layered polymer technologies, such as those used in Capsugel® Enprotect® capsules
Discover how Capsugel® Enprotect® capsule’s bi-layered polymer technology enables targeted enteric delivery—without the need for post-filling coating.
This Product Specification Brochure provides an overview of the Capsugel® Enprotect® capsule. It details the capsule’s composition, performance, data on dissolution,…
Capsugel® Enprotect® is a ready-to-use enteric capsule with acid resistance up to pH 6.0, eliminating the need for post-filling coating. This scientific brochure…
This study proposes an innovative and scalable solution to increase oral bioavailability of therapeutic peptides